Aster Capital Management (Difc) LTD Royalty Pharma PLC Call Options Transaction History
Aster Capital Management (Difc) LTD
- $198 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPRX
# of Institutions
527Shares Held
303MCall Options Held
1.46MPut Options Held
309K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.07 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$478 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...